ST. LOUIS, MO — May 27, 2025 — WashU Medicine Ophthalmology and Visual Science’s Rajendra S. Apte, MD, PhD, Paul A. Cibis Distinguished Professor and Vice Chair of Innovation and Translation, has been named the 2025 Snell Memorial Lecturer at the University of Rochester’s Flaum Eye Institute.
Rajendra S Apte, MD, PhD
Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences; Vice Chair for Innovation and Translation
- Email: apte@nospam.wustl.edu
- Retina
- Lab Website
- Research Profile
-
Apte delivered his keynote address on May 23, 2025 during the prestigious Rochester Ophthalmology Conference, an annual event that convenes top experts to explore advances in eye care and vision research. His lecture, titled “Aging, Inflammation, and Metabolic Processes Involved in AMD Pathogenesis and the Development of Novel Treatments,” examined the intricate biological processes that contribute to age-related macular degeneration (AMD) and the path toward more effective therapies.
“It was an incredible honor to deliver the 69th Snell Memorial lecture at Flaum Eye Institute at University of Rochester and discuss the cutting-edge research at the John F. Hardesty, MD Department of Ophthalmology and Visual Sciences at WashU Medicine.” said Apte.
An internationally respected leader in retinal disease research, Apte’s work has shaped current understanding of the immune and metabolic factors driving AMD. His contributions have opened doors to innovative strategies targeting the root causes of this vision-threatening condition.
The Snell Memorial Lecture honors excellence in ophthalmology by recognizing individuals whose work has transformed the field. Apte joins an esteemed group of vision scientists and clinicians whose groundbreaking research continues to impact patient outcomes worldwide.
The Rochester Ophthalmology Conference is hosted by the University of Rochester’s Flaum Eye Institute. For full details on this year’s speakers and agenda, read more here. For more information on Apte’s Lab, please click here.
About WashU Medicine
WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with 2,900 faculty. Its National Institutes of Health (NIH) research funding portfolio is the second largest among U.S. medical schools and has grown 56% in the last seven years. Together with institutional investment, WashU Medicine commits well over $1 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently within the top five in the country, with more than 1,900 faculty physicians practicing at 130 locations and who are also the medical staffs of Barnes-Jewish and St. Louis Children’s hospitals of BJC HealthCare. WashU Medicine has a storied history in MD/PhD training, recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.